Enovis to Showcase 2 Electrotherapy Systems at APTA CSM 2024
Enovis announced the commercial launch of the newest additions to its Chattanooga electrotherapy portfolio, both powered by VMS, a Chattanooga proprietary waveform.
Enovis announced the commercial launch of the newest additions to its Chattanooga electrotherapy portfolio, both powered by VMS, a Chattanooga proprietary waveform.
This is the second consecutive year Zynex has appeared on the Financial Times annual list of The Americas' Fastest Growing Companies.
Rehabilitation to address distorted body perception in stroke survivors may improve outcomes, according to researchers in a new study.
By improving strategies for imaging lipedema, researchers hope to improve treatment and rehabilitation of the condition.
An NIH-funded clinical trial investigating ESStim, a brain stimulation technology to treat carpal tunnel syndrome, has advanced to Phase II.
Hyperice announces two new products within their heat therapy category, Venom Go and Venom 2, alongside HyperHeat technology.
Using mobile phones, tablets, and other electronic devices can lead to a chronic pain condition dubbed tech neck.
Sustained acoustic medicine (SAM) delivered by the sam device from Zetroz Systems is effective in soft-tissue injury healing, a study notes.
OMRON Healthcare Inc launches Focus TENS Therapy for Knee, a wearable device that combines TENS technology with wireless capabilities to help relieve chronic, arthritic and acute pain associated with exercise strain or daily activity.
Parker Labs HELIX topical pain creams are in three formulations – Tri-Active Therapy Cream, Helix CBD Therapy Cream, and CBD Clinical Cream.
Frank Long, MS, takes a look at today’s advanced technologies designed to be an adjunct to a therapist's healing hands to help manage pain, in this feature for the August/September 2021 issue of Physical Therapy Products.
Challenges transitioning new clinicians from academic training to professional practice tops ECRI’s 2024 list of top 10 patient safety concerns for 2024.